
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.1B | -- | -- | $1.28 | -- |
07/30/2025 | Q2 | $1.1B | -- | -- | $1.38 | -- |
04/30/2025 | Q1 | $1.1B | $1.1B | $1.11 | $1.42 | -$0.31 |
02/05/2025 | Q4 | $1.1B | $1.1B | $1.01 | $0.99 | $0.02 |
11/05/2024 | Q3 | $1.1B | $1.1B | $1.16 | $1.38 | -$0.22 |
07/31/2024 | Q2 | $1.2B | $1.2B | $1.36 | $1.61 | -$0.25 |
04/30/2024 | Q1 | $1.2B | $1.2B | $1.46 | $1.52 | -$0.06 |
02/05/2024 | Q4 | $1.1B | $1.1B | $0.83 | $1.22 | -$0.39 |
11/01/2023 | Q3 | -- | -- | $1.23 | $1.60 | -$0.37 |
08/03/2023 | Q2 | -- | -- | $1.73 | $2.08 | -$0.35 |
05/03/2023 | Q1 | -- | -- | $1.67 | $1.89 | -$0.22 |
02/06/2023 | Q4 | -- | -- | $1.32 | $1.09 | $0.23 |
10/26/2022 | Q3 | -- | -- | $1.18 | $1.34 | -$0.16 |
07/28/2022 | Q2 | -- | -- | $1.42 | $1.32 | $0.10 |
05/02/2022 | Q1 | -- | -- | $1.56 | $1.16 | $0.40 |
02/03/2022 | Q4 | -- | -- | $0.82 | $0.91 | -$0.09 |
11/01/2021 | Q3 | -- | -- | $1.14 | $1.16 | -$0.02 |
08/02/2021 | Q2 | -- | -- | $1.36 | $1.44 | -$0.08 |
04/28/2021 | Q1 | -- | -- | $1.47 | $1.20 | $0.27 |
02/04/2021 | Q4 | -- | -- | $0.69 | $0.93 | -$0.24 |
10/29/2020 | Q3 | -- | -- | $1.16 | $0.90 | $0.26 |
08/03/2020 | Q2 | -- | -- | $0.82 | $0.32 | $0.50 |
05/01/2020 | Q1 | -- | -- | $1.06 | $1.09 | -$0.03 |
02/05/2020 | Q4 | -- | -- | $1.48 | $0.96 | $0.52 |
10/30/2019 | Q3 | -- | -- | $0.84 | $1.18 | -$0.34 |
07/31/2019 | Q2 | -- | -- | $1.20 | $1.44 | -$0.24 |
05/01/2019 | Q1 | -- | -- | $1.19 | $1.22 | -$0.03 |
02/07/2019 | Q4 | -- | -- | $0.77 | -- | -- |
10/29/2018 | Q3 | -- | -- | $0.91 | -- | -- |
07/31/2018 | Q2 | -- | -- | $1.16 | -- | -- |
05/01/2018 | Q1 | -- | -- | $1.02 | -- | -- |
02/07/2018 | Q4 | -- | -- | $0.37 | -- | -- |
10/25/2017 | Q3 | -- | -- | $0.68 | -- | -- |
07/26/2017 | Q2 | -- | -- | $1.04 | -- | -- |
04/26/2017 | Q1 | -- | -- | $0.48 | -- | -- |
02/09/2017 | Q4 | -- | -- | $0.31 | -- | -- |
10/27/2016 | Q3 | -- | -- | $0.43 | -- | -- |
07/28/2016 | Q2 | -- | -- | $0.61 | -- | -- |
04/27/2016 | Q1 | -- | -- | $0.82 | -- | -- |
02/03/2016 | Q4 | -- | -- | -$0.44 | -- | -- |
10/28/2015 | Q3 | -- | -- | $0.75 | -- | -- |
The Timken reported $1.1B worth of top line sales in its most recent quarter.
The Timken announced earnings per share of $1.11 which represents a miss of analyst forecast a $1.42 per share.
The Timken reported $358.7M that represents $5.09 per share over the last quarter.
The Timken's earnings are forecast to grow from $4.99 per share to $5.62 per share next year representing an increase of 6.39%.
The Timken's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.